Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4'-fluoro-4-(4-(2-thioxo-1-benzimidazolinyl)piperidino)butyrophenone
2. Dd 3480
1. 57648-21-2
2. Tolopelon
3. Dd-3480
4. 1-(1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl)-2-benzimidazolinethione
5. 626dq7n19l
6. Timiperone (jan)
7. Timiperone [jan]
8. 4-fluoro-4-(4-(2-thioxo-1-benzimidazolinyl)piperidino)butyrophenone
9. 1-butanone, 4-(4-(2,3-dihydro-2-thioxo-1h-benzimidazol-1-yl)-1-piperidinyl)-1-(4-fluorophenyl)-
10. Timiperona
11. Timiperonum
12. Timiperone [inn:jan]
13. Timiperonum [inn-latin]
14. Timiperona [inn-spanish]
15. 1-butanone, 4-[4-(2,3-dihydro-2-thioxo-1h-benzimidazol-1-yl)-1-piperidinyl]-1-(4-fluorophenyl)-
16. Ncgc00182555-01
17. Einecs 260-880-9
18. Dd 3480
19. Unii-626dq7n19l
20. Tolopelon (tn)
21. Timiperone [mi]
22. Timiperone [inn]
23. 4'-fluoro-4-(4-(2-thioxo-1-benzimidazolinyl)piperidino)butyrophenone
24. Butyrophenone, 4'-fluoro-4-(4-(2-thioxobenzimidazol-1-yl)piperidino)-
25. Dsstox_cid_3673
26. 2-benzimidazolinethione, 1-(1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl)-
27. Timiperone [mart.]
28. 1-(4-fluorophenyl)-4-[4-(2-sulfanylidene-3h-benzimidazol-1-yl)piperidin-1-yl]butan-1-one
29. Dsstox_rid_77139
30. Timiperone [who-dd]
31. Dsstox_gsid_23673
32. Schembl145839
33. Chembl2107117
34. Dtxsid9023673
35. Schembl11797177
36. Chebi:135631
37. Zinc3873392
38. Tox21_113628
39. Akos025396887
40. Ncgc00387301-01
41. 4-(4-(2,3-dihydro-2-thioxo-1h-benzimidazol-1-yl)-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone
42. Cas-57648-21-2
43. Ft-0675238
44. D02035
45. 648t212
46. Q7806745
47. 1-[1-(3-(4-fluorobenzoyl)propyl)-4-piperidyl]-2-mercaptobenzimidazole
48. 1-(4-fluorophenyl)-4-[4-(2-thioxo-2,3-dihydro-1h-benzimidazol-1-yl)piperidin-1-yl]butan-1-one
| Molecular Weight | 397.5 g/mol |
|---|---|
| Molecular Formula | C22H24FN3OS |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 397.16241173 g/mol |
| Monoisotopic Mass | 397.16241173 g/mol |
| Topological Polar Surface Area | 67.7 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 558 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Timiperone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Timiperone, including repackagers and relabelers. The FDA regulates Timiperone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Timiperone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Timiperone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Timiperone supplier is an individual or a company that provides Timiperone active pharmaceutical ingredient (API) or Timiperone finished formulations upon request. The Timiperone suppliers may include Timiperone API manufacturers, exporters, distributors and traders.
click here to find a list of Timiperone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Timiperone Drug Master File in Japan (Timiperone JDMF) empowers Timiperone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Timiperone JDMF during the approval evaluation for pharmaceutical products. At the time of Timiperone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Timiperone suppliers with JDMF on PharmaCompass.
Timiperone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Timiperone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Timiperone GMP manufacturer or Timiperone GMP API supplier for your needs.
A Timiperone CoA (Certificate of Analysis) is a formal document that attests to Timiperone's compliance with Timiperone specifications and serves as a tool for batch-level quality control.
Timiperone CoA mostly includes findings from lab analyses of a specific batch. For each Timiperone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Timiperone may be tested according to a variety of international standards, such as European Pharmacopoeia (Timiperone EP), Timiperone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Timiperone USP).
LOOKING FOR A SUPPLIER?
